Pages that link to "Q34345655"
Jump to navigation
Jump to search
The following pages link to Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure (Q34345655):
Displaying 50 items.
- Latency: the hidden HIV-1 challenge (Q25255905) (← links)
- Redefining the viral reservoirs that prevent HIV-1 eradication (Q26827255) (← links)
- Recent developments in human immunodeficiency virus-1 latency research (Q27013114) (← links)
- An "escape clock" for estimating the turnover of SIV DNA in resting CD4⁺ T cells (Q28482134) (← links)
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation (Q29619611) (← links)
- HIV pathogenesis: dynamics and genetics of viral populations and infected cells (Q30425443) (← links)
- Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro (Q30558754) (← links)
- The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance (Q33212237) (← links)
- Limits on replenishment of the resting CD4 T cell reservoir for HIV in patients on HAART (Q33296883) (← links)
- Reappearance of an 11-year-old sequence in an HIV-1 infected patient during treatment interruption (Q33302143) (← links)
- Low-level HIV-1 replication and the dynamics of the resting CD4 T cell reservoir for HIV-1 in the setting of HAART. (Q33313038) (← links)
- Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy (Q33510903) (← links)
- A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4 T cells of viremic patients (Q33724247) (← links)
- Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy (Q33737646) (← links)
- Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus (Q33908838) (← links)
- Short communication: Activating stimuli enhance immunotoxin-mediated killing of HIV-infected macrophages (Q34085094) (← links)
- Molecular Characterization, Reactivation, and Depletion of Latent HIV (Q34263657) (← links)
- Impact of latently infected cells on strain archiving within HIV hosts (Q34331710) (← links)
- Reduced evolutionary rates in HIV-1 reveal extensive latency periods among replicating lineages (Q34362894) (← links)
- The HBV drug entecavir - effects on HIV-1 replication and resistance (Q34639926) (← links)
- Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy (Q34647680) (← links)
- Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments (Q34975321) (← links)
- Latency in human immunodeficiency virus type 1 infection: no easy answers (Q35044157) (← links)
- Measuring turnover of SIV DNA in resting CD4 T cells using pyrosequencing: implications for the timing of HIV eradication therapies (Q35141776) (← links)
- HIV-1 seronegativity in a child with proved perinatal HIV infection on HAART (Q35531964) (← links)
- The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets (Q35917148) (← links)
- Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules (Q35980789) (← links)
- Maintenance of viral suppression in HIV-1-infected HLA-B*57 elite suppressors despite CTL escape mutations (Q36238124) (← links)
- Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication (Q36330062) (← links)
- Dynamics of the resting CD4( ) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age. (Q36390881) (← links)
- Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities (Q36557330) (← links)
- Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. (Q36673315) (← links)
- Experimental approaches to the study of HIV-1 latency (Q36708954) (← links)
- Treatment implications of the latent reservoir for HIV-1. (Q36857114) (← links)
- Regulation of HIV-1 latency by T-cell activation. (Q36887625) (← links)
- Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads (Q36943833) (← links)
- The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation (Q36968375) (← links)
- Immunology of pediatric HIV infection (Q37080573) (← links)
- Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips (Q37133236) (← links)
- Increased mutations in Env and Pol suggest greater HIV-1 replication in sputum-derived viruses compared with blood-derived viruses (Q37180837) (← links)
- Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency (Q37348467) (← links)
- Waking up the sleepers: HIV latency and reactivation (Q37364293) (← links)
- Modeling HIV persistence, the latent reservoir, and viral blips (Q37365718) (← links)
- HIV latency (Q37974218) (← links)
- Assessing the cost effectiveness of pre-exposure prophylaxis for HIV prevention in the US. (Q38165803) (← links)
- HIV-1 latency: an update of molecular mechanisms and therapeutic strategies (Q38204866) (← links)
- HIV-1 drug resistance genotypic profiles in children with undetectable plasma viremia during antiretroviral therapy (Q38411323) (← links)
- Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. (Q38449098) (← links)
- Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue (Q38682294) (← links)
- Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor (Q39600778) (← links)